Can infrequent zoledronate dosing in early postmenopause prevent fractures?Study examines zoledronate dosing at baseline and at five years to determine effects on vertebral fracture prevention in early postmenopausal women. NDSAC releases final recommendations for cetirizine in childrenEffective Jan. 21, pharmacists should take note of these recommendations for cetirizine or its salts. POP QUIZ: Constella for constipation in children Constella (linaclotide) capsules were recently approved by Health Canada for use in children with constipation. New guidance on caring for newborns at risk of withdrawal due to parental substance use The Canadian Pediatric Society provides updated evidence-based advice as incidence of neonatal abstinence syndrome is rising. Emergency contraception pill could be an alternative to mifepristone for abortions, study suggests Now used in two-thirds of U.S. abortions, mifepristone blocks a hormone needed to sustain a pregnancy. It’s typically used with misoprostol, which causes contractions and bleeding. Oxytocin nasal spray helps combat apathy in frontotemporal dementia: study Caregivers noticed changes in behaviour with treatment over six weeks. Recall: Health Canada pulls compounded semaglutide over unauthorized ingredient Novo Nordisk Canada has also warned that compounded semaglutide may expose patients to health risks. Adverse drug events in outpatient settings ADEs in the outpatient setting are common, occuring in approximately 5% of patients. Of these, 22% are considered preventable. Antihypertensives and eczematous dermatitis Rates of eczematous dermatitis have been increasing among older adults. U.S. FDA issues new warning for RSV vaccines Arexvy and Abrysvo Either vaccine may slightly increase the risk of Guillain-Barré syndrome within 42 days of administration. First Previous 4 5 6 7 8 Next Last
